Cargando…
Diuretic-Resistant Ascites Following Laparoscopic Surgery in a Patient With Chronic Myeloid Leukemia on Imatinib Therapy
Imatinib mesylate is a tyrosine kinase inhibitor with high efficacy in the treatment of chronic myeloid leukemia (CML). Although fluid retention is a common adverse effect of imatinib, it rarely necessitates discontinuation of therapy. Isolated ascites has not been reported as a complication of imat...
Autores principales: | Pappa, Efthymia, Gkeka, Marina, Kiki, Ifigeneia, Gourna, Pagona, Christopoulos, Constantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935277/ https://www.ncbi.nlm.nih.gov/pubmed/33728144 http://dx.doi.org/10.7759/cureus.13127 |
Ejemplares similares
-
Thyroid hormone treatment and SARS-CoV-2 infection
por: Pappa, Efthymia, et al.
Publicado: (2022) -
Follicular Lymphoma Secondary to Chronic Myeloid Leukemia During Treatment With Imatinib
por: Geelani, Sajad A, et al.
Publicado: (2022) -
Imatinib-Induced Lichen Planus in Chronic Myeloid Leukemia: A Case Series
por: Yelisetti, Anuhya, et al.
Publicado: (2023) -
Case Report: Clinically amyopathic dermatomyositis presenting acutely with isolated facial edema
por: Pappa, Efthymia, et al.
Publicado: (2018) -
Novel Score-based Decision Approach in Chronic Myeloid Leukemia Patients After Acute Toxic Imatinib-induced Liver Injury
por: Lopina, Nataliia, et al.
Publicado: (2019)